Volume 33, Issue 6 pp. 715-725
Original Article

Mutations in the promoter region of the aldolase B gene that cause hereditary fructose intolerance

Erin M. Coffee

Corresponding Author

Erin M. Coffee

Molecular Biology, Cell Biology, and Biochemistry Program, Boston, MA, 02215 USA

[email protected]

Telephone: +617-353-5310, Fax: +617-358-0338, [email protected]

Search for more papers by this author
Dean R. Tolan

Corresponding Author

Dean R. Tolan

Molecular Biology, Cell Biology, and Biochemistry Program, Boston, MA, 02215 USA

Biology Department, Boston University, 5 Cummington Street, Boston, MA, 02215 USA

[email protected]

Telephone: +617-353-5310, Fax: +617-358-0338, [email protected]

Search for more papers by this author
First published: 30 September 2010
Citations: 30

Communicated by: Guy Besley

Competing interest: None declared

Electronic Supplementary Material:

The online version of this article (doi:10.1007/s10545-010-9192-5) contains supplementary material, which is available to authorized users.

Abstract

Hereditary fructose intolerance (HFI) is a potentially fatal inherited metabolic disease caused by a deficiency of aldolase B activity in the liver and kidney. Over 40 disease-causing mutations are known in the protein-coding region of ALDOB. Mutations upstream of the protein-coding portion of ALDOB are reported here for the first time. DNA sequence analysis of 61 HFI patients revealed single base mutations in the promoter, intronic enhancer, and the first exon, which is entirely untranslated. One mutation, g.−132G>A, is located within the promoter at an evolutionarily conserved nucleotide within a transcription factor-binding site. A second mutation, IVS1+1G>C, is at the donor splice site of the first exon. In vitro electrophoretic mobility shift assays show a decrease in nuclear extract-protein binding at the g.−132G>A mutant site. The promoter mutation results in decreased transcription using luciferase reporter plasmids. Analysis of cDNA from cells transfected with plasmids harboring the IVS1+1G>C mutation results in aberrant splicing leading to complete retention of the first intron (~5 kb). The IVS1+1G>C splicing mutation results in loss of luciferase activity from a reporter plasmid. These novel mutations in ALDOB represent 2% of alleles in American HFI patients, with IVS1+1G>C representing a significantly higher allele frequency (6%) among HFI patients of Hispanic and African-American ethnicity.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.